Strategies to protect the transplanted liver from hepatitis B virus infection
β Scribed by Timothy L. Pruett
- Publisher
- John Wiley and Sons
- Year
- 2008
- Tongue
- English
- Weight
- 53 KB
- Volume
- 14
- Category
- Article
- ISSN
- 1527-6465
- DOI
- 10.1002/lt.21424
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
To determine the safety and efficacy of ganciclovir usually experience progressive liver disease over an treatment of hepatitis B virus (HBV) infection after liver accelerated time course and pose a difficult managetransplantation, nine patients (seven males, two females; ment challenge. The treatm
From the 1 Division of Liver Transplantation and the 2 Division of Pathology, Mayo Clinic lents/mL (geq/mL) as the lowest level of detection. 7
The outcome of patients with hepatitis B virus (HBV) and human immunodeficiency virus (HIV) referred for liver transplantation (LT) is unknown. A high frequency of lamivudine-resistant (LAM-R) HBV infection may increase the risk of liver-related death pre-transplantation and prophylaxis failure post